| Address: | 481 Corporate Dr, Elmwood Park, NJ 07407, USA |
|---|---|
| Postal code: | 07407 |
| Phone: | (800) 229-5227 |
| Website: | http://www.4kscore.com/ |
Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore® test with defined coverage criteria, effective December 30, 2019.
The 4Kscore® Test is used in men after an abnormal prostate-specific antigen (PSA) or digital rectal exam (DRE) result. It provides the risk of
finding high-grade prostate cancer if biopsy were to be performed and has the potential to minimize avoidable biopsy procedures, reducing
costs associated with identifying and treating prostate cancer. The goal for prostate cancer early detection should be to avoid over-diagnosis
and over-treatment, which happens when an abnormal PSA leads directly to a prostate biopsy, but also to avoid under-diagnosis and delayed
treatment of aggressive cancers due to reduced testing.